Imipramine 25mg Tablets

Manufacturer OXFORD PHARMACEUTICALS Active Ingredient Imipramine Tablets(im IP ra meen) Pronunciation im-IP-ra-meen
WARNING: Drugs like this one have raised the chance of suicidal thoughts or actions in children and young adults. The risk may be greater in people who have had these thoughts or actions in the past. All people who take this drug need to be watched closely. Call the doctor right away if signs like depression, nervousness, restlessness, grouchiness, panic attacks, or changes in mood or actions are new or worse. Call the doctor right away if any thoughts or actions of suicide occur.This drug is not approved for use in all children. Talk with the doctor to be sure that this drug is right for your child. @ COMMON USES: It is used to treat depression.It is used to help prevent bedwetting in children.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Antidepressant
đŸ§Ŧ
Pharmacologic Class
Tricyclic Antidepressant (TCA); Norepinephrine and Serotonin Reuptake Inhibitor
🤰
Pregnancy Category
Category D
✅
FDA Approved
Mar 1959
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Imipramine is a medication primarily used to treat depression. It belongs to a class of drugs called tricyclic antidepressants (TCAs). It works by helping to restore the balance of certain natural chemicals in the brain. It can also be used to treat bedwetting in children.
📋

How to Use This Medicine

Taking Your Medication Correctly

To get the most benefit from your medication, it's essential to follow your doctor's instructions carefully. Read all the information provided with your medication and follow the instructions precisely. If you experience drowsiness after taking this medication, consult your doctor, as they may need to adjust your dosage or the timing of when you take it. Continue taking your medication as directed by your doctor or healthcare provider, even if you're feeling well.

Storing and Disposing of Your Medication

To maintain the effectiveness and safety of your medication, store it at room temperature, protected from light, and in a dry place. Avoid storing it in a bathroom. Keep all medications in a secure location, out of the reach of children and pets. When disposing of unused or expired medications, do not flush them down the toilet or pour them down the drain unless instructed to do so by your pharmacist. Instead, check with your pharmacist for guidance on the best disposal method or explore local drug take-back programs.

What to Do If You Miss a Dose

If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Avoid taking two doses at the same time or taking extra doses. If you take your daily dose at bedtime and miss a dose, do not take the missed dose the next morning.
💡

Lifestyle & Tips

  • Avoid alcohol and other CNS depressants, as they can increase drowsiness and other side effects.
  • Be cautious when driving or operating machinery until you know how this medication affects you, as it can cause drowsiness, dizziness, or blurred vision.
  • Avoid sudden changes in position (e.g., standing up quickly) to minimize dizziness from low blood pressure.
  • Maintain good oral hygiene and use sugarless gum or candy to help with dry mouth.
  • Increase fiber and fluid intake to help prevent constipation.
  • Do not stop taking this medication suddenly without consulting your doctor, as it can lead to withdrawal symptoms.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Depression: Initial 75 mg/day in divided doses, gradually increase to 150-200 mg/day. Max 300 mg/day for hospitalized patients.
Dose Range: 25 - 300 mg

Condition-Specific Dosing:

depression: Initial 75 mg/day in divided doses or at bedtime, gradually increase by 25-50 mg increments to 150-200 mg/day. Max 300 mg/day for severe depression (hospitalized patients).
panic_disorder: Initial 25 mg at bedtime, gradually increase to 75-150 mg/day. Max 200 mg/day.
neuropathic_pain: Off-label: Initial 10-25 mg at bedtime, gradually increase to 75-150 mg/day.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Nocturnal Enuresis (6-12 years): Initial 25 mg 1 hour before bedtime. If inadequate, increase to 50 mg (6-12 years) or 75 mg (>12 years). Max 2.5 mg/kg/day. Depression (off-label): Not routinely recommended due to black box warning and safer alternatives.
Adolescent: Nocturnal Enuresis (>12 years): 75 mg 1 hour before bedtime. Depression (off-label): Not routinely recommended due to black box warning and safer alternatives.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No specific adjustment recommended, use with caution.
Moderate: No specific adjustment recommended, use with caution. Monitor for adverse effects.
Severe: Use with caution, consider lower doses and monitor for adverse effects due to potential accumulation of active metabolites.
Dialysis: Not significantly dialyzable. Use with caution, monitor for adverse effects.

Hepatic Impairment:

Mild: Use with caution.
Moderate: Consider lower initial doses and slower titration. Monitor liver function and plasma levels.
Severe: Contraindicated or use with extreme caution; significant dose reduction required. Monitor liver function and plasma levels closely.
Confidence: Medium

Pharmacology

đŸ”Ŧ

Mechanism of Action

Imipramine is a tricyclic antidepressant (TCA) that primarily inhibits the reuptake of norepinephrine (NE) and serotonin (5-HT) into presynaptic neurons, thereby increasing the concentrations of these neurotransmitters in the synaptic cleft. It also possesses significant anticholinergic, antihistaminic (H1-receptor blocking), and alpha1-adrenergic blocking properties, which contribute to its side effect profile.
📊

Pharmacokinetics

Absorption:

Bioavailability: 29-77% (variable due to extensive first-pass metabolism)
Tmax: 1-4 hours (imipramine); 2-8 hours (desipramine)
FoodEffect: Food may delay Tmax but generally does not significantly affect AUC or Cmax.

Distribution:

Vd: 10-20 L/kg
ProteinBinding: ~90% (to plasma proteins)
CnssPenetration: Yes (readily crosses the blood-brain barrier)

Elimination:

HalfLife: Imipramine: 6-20 hours; Desipramine: 12-76 hours (highly variable)
Clearance: Not available (highly variable due to extensive metabolism)
ExcretionRoute: Primarily renal (urine) as metabolites (approximately 80%); small amount in feces (approximately 20%).
Unchanged: <5% (in urine)
âąī¸

Pharmacodynamics

OnsetOfAction: Antidepressant effects typically begin within 1-4 weeks; full therapeutic effect may take 4-6 weeks. Sedative and anticholinergic effects may occur sooner.
PeakEffect: Antidepressant effect: 4-6 weeks.
DurationOfAction: Related to half-life, effects persist for 24 hours with once-daily dosing.
Confidence: Medium

Safety & Warnings

âš ī¸

BLACK BOX WARNING

Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of Major Depressive Disorder (MDD) and other psychiatric disorders. Anyone considering the use of imipramine or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. Imipramine is not approved for use in pediatric patients except for patients with nocturnal enuresis.
âš ī¸

Side Effects

Important Side Effects to Report to Your Doctor Immediately

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you experience any of the following symptoms, seek medical attention right away:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high or low blood pressure, including:
+ Severe headache or dizziness
+ Passing out
+ Changes in eyesight
Confusion
Hallucinations (seeing or hearing things that are not there)
Sleep disturbances, including trouble sleeping or bad dreams
Erectile dysfunction or changes in sex interest
Fever, chills, or sore throat
Unexplained bruising or bleeding
Feeling extremely tired or weak
Yellowing of the skin or eyes (jaundice)
Chest pain or pressure
Fast or abnormal heartbeat
Shortness of breath
Sudden weight gain or swelling in the arms or legs
Weakness on one side of the body
Trouble speaking or thinking
Changes in balance
Drooping on one side of the face
Blurred eyesight
Ringing in the ears
Burning, numbness, or tingling sensations
Trouble controlling body movements
Twitching
Swallowing or speaking difficulties
Seizures
Severe constipation or stomach pain (may be signs of a bowel problem)
Trouble passing urine
Swelling
Mouth irritation or mouth sores
Enlarged breasts or nipple discharge
Swelling of the testicles
Hair loss

Monitoring for High or Low Blood Sugar

If you experience any of the following symptoms, contact your doctor, as they may be signs of high or low blood sugar:
Breath that smells like fruit
Dizziness
Fast breathing
Fast heartbeat
Confusion
Sleepiness
Weakness
Flushing
Headache
Unusual thirst or hunger
Frequent urination
Shaking or sweating

Eye Problems

Some people may be at a higher risk of developing eye problems while taking this medication. Your doctor may recommend an eye exam to assess your risk. If you experience any of the following symptoms, seek medical attention right away:
Eye pain
Changes in eyesight
Swelling or redness in or around the eye

Serotonin Syndrome

A rare but potentially life-threatening condition called serotonin syndrome may occur, especially if you are taking certain other medications. If you experience any of the following symptoms, seek medical attention immediately:
Agitation
Changes in balance
Confusion
Hallucinations
Fever
Fast or abnormal heartbeat
Flushing
Muscle twitching or stiffness
Seizures
Shivering or shaking
Excessive sweating
Severe diarrhea, stomach upset, or vomiting
Severe headache

Other Possible Side Effects

While many people may not experience any side effects or only minor ones, it is essential to report any of the following symptoms to your doctor if they bother you or persist:
Dizziness
Sleepiness
Fatigue
Weakness
Dry mouth
Constipation
Diarrhea
Stomach pain
Upset stomach
Vomiting
Decreased appetite
Changes in taste
Stomach cramps
Weight gain or loss
Excessive sweating
Flushing
* Headache

Reporting Side Effects

If you have any questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Worsening depression or thoughts about harming yourself (especially at the beginning of treatment or after a dose change)
  • New or worsening anxiety, agitation, panic attacks, insomnia, irritability, hostility, impulsivity, or restlessness
  • Unusual changes in behavior or mood
  • Fast, pounding, or irregular heartbeat
  • Chest pain
  • Severe dizziness or fainting
  • Seizures
  • Difficulty urinating or severe constipation
  • Blurred vision or eye pain (especially if you have glaucoma)
  • Yellowing of the skin or eyes (jaundice)
  • Unexplained fever or sore throat
  • Rash or hives
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced.
If you have recently had a heart attack.
If you have taken certain medications for depression or Parkinson's disease within the last 14 days, including isocarboxazid, phenelzine, tranylcypromine, selegiline, or rasagiline, as this may lead to very high blood pressure.
If you are currently taking linezolid or methylene blue, as these medications can interact with this drug.
* If you are breastfeeding, as you should not breastfeed while taking this medication.

This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health problems with your doctor and pharmacist. They will help you determine if it is safe to take this medication with your other medications and health conditions. Never start, stop, or change the dose of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

Important Warnings and Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Your doctor may advise you to stop taking this drug before certain surgical procedures, and will provide guidance on when to resume taking it after the surgery or procedure.

Caution with Daily Activities

Until you understand how this medication affects you, avoid driving and other tasks that require alertness. To minimize the risk of dizziness or fainting, rise slowly from a sitting or lying position. Be cautious when navigating stairs.

Discontinuing the Medication

Do not stop taking this medication abruptly without consulting your doctor, as this may increase the risk of side effects. If you need to discontinue the medication, your doctor will provide instructions on how to gradually stop taking it.

Special Considerations

If you have diabetes (high blood sugar), closely monitor your blood sugar levels. Before consuming alcohol, marijuana, or other forms of cannabis, or taking prescription or over-the-counter medications that may impair your actions, consult with your doctor.

Potential Side Effects and Interactions

It may take several weeks to experience the full effects of this medication. You may be more susceptible to sunburn, so avoid exposure to sunlight, sunlamps, and tanning beds. Use sunscreen and wear protective clothing and eyewear to minimize your risk. In hot weather or during physical activity, drink plenty of fluids to prevent dehydration.

Monitoring and Precautions

Your doctor may recommend an electrocardiogram (ECG) before starting this medication and during treatment. If you are 65 years or older, use this medication with caution, as you may be more prone to side effects.

Pregnancy and Breastfeeding

If you are pregnant or plan to become pregnant, discuss the benefits and risks of taking this medication with your doctor.
🆘

Overdose Information

Overdose Symptoms:

  • Severe drowsiness or confusion
  • Hallucinations
  • Agitation or restlessness
  • Dilated pupils
  • Fast, irregular, or pounding heartbeat
  • Low blood pressure (dizziness, fainting)
  • Severe dry mouth
  • Urinary retention
  • Seizures
  • Coma
  • Respiratory depression
  • Cardiac arrhythmias (e.g., QRS widening, ventricular tachycardia, Torsades de Pointes)

What to Do:

Seek immediate emergency medical attention. Call 911 or Poison Control at 1-800-222-1222. Treatment involves supportive care, gastric decontamination (if appropriate), activated charcoal, and management of cardiac arrhythmias and seizures.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Monoamine Oxidase Inhibitors (MAOIs) - risk of serotonin syndrome, hyperpyrexia, convulsions, death. Allow 14 days washout period between MAOIs and imipramine.
  • Cisapride - increased risk of QT prolongation and arrhythmias.
  • Linezolid, Methylene Blue (IV) - risk of serotonin syndrome.
🔴

Major Interactions

  • Other CNS depressants (e.g., alcohol, benzodiazepines, opioids, sedatives, hypnotics) - additive CNS depression.
  • Anticholinergic agents (e.g., atropine, scopolamine, antihistamines, antipsychotics) - additive anticholinergic effects (severe constipation, urinary retention, paralytic ileus, hyperpyrexia).
  • Sympathomimetics (e.g., epinephrine, norepinephrine, phenylephrine, pseudoephedrine) - potentiated cardiovascular effects (hypertension, arrhythmias).
  • QT-prolonging drugs (e.g., antiarrhythmics like quinidine, procainamide; certain antipsychotics like thioridazine; macrolide antibiotics; fluoroquinolones) - increased risk of ventricular arrhythmias, Torsades de Pointes.
  • CYP2D6 inhibitors (e.g., fluoxetine, paroxetine, quinidine, cimetidine) - significantly increase imipramine and desipramine plasma concentrations, leading to increased toxicity.
  • Thyroid hormones - increased risk of cardiac arrhythmias and toxicity.
🟡

Moderate Interactions

  • Antihypertensives (e.g., guanethidine, clonidine, reserpine) - imipramine may antagonize their hypotensive effects.
  • Oral anticoagulants (e.g., warfarin) - potential for increased anticoagulant effect (monitor INR).
  • Barbiturates - may decrease imipramine plasma levels due to enzyme induction.
  • Nicotine - may decrease imipramine plasma levels due to enzyme induction.
đŸŸĸ

Minor Interactions

  • Not available (interactions are generally categorized as significant due to TCA's narrow therapeutic index and side effect profile)

Monitoring

đŸ”Ŧ

Baseline Monitoring

Complete Medical History & Physical Exam

Rationale: To identify pre-existing conditions (e.g., cardiac disease, glaucoma, urinary retention, seizure disorder) that may contraindicate or require caution with imipramine.

Timing: Prior to initiation

Electrocardiogram (ECG)

Rationale: To assess for pre-existing cardiac conduction abnormalities (e.g., prolonged QT interval, bundle branch block) due to imipramine's cardiotoxic potential.

Timing: Prior to initiation (especially in elderly or patients with cardiac risk factors)

Liver Function Tests (LFTs)

Rationale: To assess hepatic function, as imipramine is extensively metabolized by the liver.

Timing: Prior to initiation

Renal Function Tests (BUN, Creatinine)

Rationale: To assess renal function, especially in patients with pre-existing renal impairment.

Timing: Prior to initiation

Electrolytes (Potassium, Magnesium)

Rationale: To identify electrolyte imbalances that could increase the risk of cardiac arrhythmias.

Timing: Prior to initiation

Ophthalmologic Exam (intraocular pressure)

Rationale: To rule out narrow-angle glaucoma, which can be exacerbated by anticholinergic effects.

Timing: Prior to initiation (if indicated)

📊

Routine Monitoring

Mental Status & Clinical Response

Frequency: Weekly during titration, then monthly or as clinically indicated

Target: Improvement in mood, sleep, appetite, energy; reduction in depressive symptoms.

Action Threshold: Worsening depression, emergence of suicidality, agitation, mania/hypomania, or severe adverse effects warrant immediate re-evaluation and potential dose adjustment or discontinuation.

Blood Pressure & Heart Rate

Frequency: Weekly during titration, then periodically

Target: Within normal limits; monitor for orthostatic hypotension and tachycardia.

Action Threshold: Significant orthostatic hypotension (e.g., >20 mmHg drop in systolic BP) or persistent tachycardia warrants dose reduction or discontinuation.

Electrocardiogram (ECG)

Frequency: Periodically, especially in elderly, those with cardiac disease, or at higher doses (e.g., >200 mg/day)

Target: Normal sinus rhythm, PR <200 ms, QRS <100 ms, QTc <450 ms (men), <470 ms (women).

Action Threshold: Significant QTc prolongation (>500 ms or >60 ms increase from baseline), new arrhythmias, or conduction delays warrant immediate discontinuation and cardiac evaluation.

Plasma Imipramine + Desipramine Levels (Therapeutic Drug Monitoring)

Frequency: After 5-7 days at a stable dose, then as clinically indicated (e.g., lack of response, suspected toxicity, drug interactions)

Target: 150-300 ng/mL (combined imipramine + desipramine)

Action Threshold: Levels below therapeutic range (consider dose increase); levels above therapeutic range (>300 ng/mL) or associated with toxicity (consider dose reduction).

Liver Function Tests (LFTs)

Frequency: Periodically, especially if signs of hepatic dysfunction or with concomitant hepatotoxic drugs.

Target: Within normal limits.

Action Threshold: Significant elevation of transaminases (>3x ULN) warrants investigation and potential discontinuation.

Weight

Frequency: Periodically

Target: Maintain stable weight.

Action Threshold: Significant weight gain warrants dietary counseling and consideration of alternative therapy.

đŸ‘ī¸

Symptom Monitoring

  • Worsening depression
  • Emergence or worsening of suicidal thoughts or behavior
  • Unusual changes in behavior (e.g., agitation, irritability, anxiety, panic attacks, insomnia, impulsivity, aggression, akathisia, hypomania, mania)
  • Dry mouth
  • Constipation
  • Blurred vision
  • Urinary retention
  • Dizziness or lightheadedness (especially on standing)
  • Sedation or drowsiness
  • Tremor
  • Palpitations or irregular heartbeat
  • Seizures
  • Confusion or disorientation (especially in elderly)

Special Patient Groups

🤰

Pregnancy

Category D. Imipramine crosses the placenta. Use during pregnancy is generally not recommended unless the potential benefit justifies the potential risk to the fetus. Neonatal withdrawal symptoms (e.g., respiratory distress, cyanosis, irritability, tremors, seizures, feeding difficulties) have been reported following third-trimester exposure.

Trimester-Specific Risks:

First Trimester: Limited data, but generally not associated with major congenital malformations. However, due to potential risks and availability of safer alternatives, caution is advised.
Second Trimester: Potential for cardiac effects in the fetus, though data is inconsistent.
Third Trimester: Risk of neonatal withdrawal syndrome (e.g., respiratory distress, cyanosis, irritability, tremors, seizures, feeding difficulties) and persistent pulmonary hypertension of the newborn (PPHN).
🤱

Lactation

L3 (Moderately Safe). Imipramine and its active metabolite desipramine are excreted into breast milk. While levels are generally low, monitor the infant for adverse effects such as sedation, poor feeding, irritability, or poor weight gain. Use with caution, especially in preterm or neonates.

Infant Risk: Low to moderate. Potential for sedation, poor feeding, irritability, or poor weight gain in breastfed infants. Monitor closely.
đŸ‘ļ

Pediatric Use

Approved for nocturnal enuresis in children aged 6 years and older. Not approved for depression in pediatric patients due to the black box warning regarding increased risk of suicidality in children, adolescents, and young adults. Use for depression is off-label and generally discouraged in favor of safer alternatives. Close monitoring for behavioral changes and suicidality is crucial if used.

👴

Geriatric Use

Elderly patients are more sensitive to the anticholinergic, sedative, and cardiovascular (e.g., orthostatic hypotension, cardiac conduction abnormalities) side effects of imipramine. Start with lower doses (e.g., 25-50 mg/day) and titrate slowly. Monitor closely for adverse effects, especially cognitive impairment, falls, and cardiac issues. Plasma levels may be higher due to reduced metabolism and clearance.

Clinical Information

💎

Clinical Pearls

  • Imipramine has significant anticholinergic side effects (dry mouth, constipation, blurred vision, urinary retention), which can be particularly problematic in elderly patients.
  • Cardiovascular effects, including orthostatic hypotension, tachycardia, and conduction abnormalities (e.g., QRS widening, QT prolongation), are dose-dependent and require careful monitoring, especially in patients with pre-existing cardiac disease.
  • Therapeutic drug monitoring (TDM) of combined imipramine and desipramine plasma levels can be useful to guide dosing, assess adherence, and investigate toxicity or lack of response.
  • Due to its sedative properties, imipramine is often dosed at bedtime, which can also help mitigate orthostatic hypotension during the day.
  • Withdrawal symptoms (e.g., nausea, vomiting, dizziness, headache, anxiety, agitation, sleep disturbances) can occur if discontinued abruptly; taper dose gradually over several weeks.
  • Imipramine has a narrow therapeutic index, making careful dosing and monitoring essential.
🔄

Alternative Therapies

  • Other Tricyclic Antidepressants (TCAs): Amitriptyline, Nortriptyline, Doxepin, Desipramine (active metabolite of imipramine)
  • Selective Serotonin Reuptake Inhibitors (SSRIs): Fluoxetine, Sertraline, Paroxetine, Citalopram, Escitalopram
  • Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs): Venlafaxine, Duloxetine, Desvenlafaxine
  • Atypical Antidepressants: Bupropion, Mirtazapine, Trazodone
  • Other treatments for nocturnal enuresis: Desmopressin, behavioral therapy (e.g., bedwetting alarms)
  • Psychotherapy (e.g., Cognitive Behavioral Therapy - CBT)
💰

Cost & Coverage

Average Cost: Varies widely, typically $10-$50 per 30 tablets (25mg)
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (Generic)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor promptly. To ensure safe and effective treatment, never share your medication with others or take someone else's medication.

This medication is accompanied by a Medication Guide, which is a valuable resource that provides important information about its use. It is crucial to read this guide carefully and review it again whenever you receive a refill of your medication. If you have any questions or concerns about this medication, do not hesitate to consult with your doctor, pharmacist, or other healthcare provider.

In the event of a suspected overdose, immediate action is necessary. Call your local poison control center or seek medical attention right away. When reporting the incident, be prepared to provide detailed information, including the name of the medication taken, the amount consumed, and the time it occurred.